Introduction {#section5-1753466619898598}
============

Asthma is one of the most common chronic lung diseases. It is a heterogeneous inflammatory disease characterised by bronchial hyperresponsiveness, coughing, wheezing, breathlessness and more frequently by partially irreversible airway obstruction. In a subset of subjects with long-term severe asthma, uncontrolled inflammation leads to irreversible changes of the bronchial wall, defined as remodelling.^[@bibr1-1753466619898598]^ Remodelling is associated with a fixed airflow limitation in lung function testing.

In severe asthma, particularly in patients with an uncontrolled disease not responding to therapy or in those patients with atypical presentations, computed tomography (CT) has been utilized to rule out asthma mimicking diagnosis. Beyond obtaining an accurate diagnosis, the utility of CT in severe asthma is limited.^[@bibr2-1753466619898598]^ The development of new CT-scanner generations and the advancement in image post-processing techniques enable an extension of the scope of examination and imaging precision. Both are the base of quantitative computed tomography (qCT)^[@bibr3-1753466619898598]^ that allows for the measurement of numerous not directly attainable parameters of the fields subjected to examination. Several studies focus on quantitative airway measurements in patients with asthma.^[@bibr4-1753466619898598][@bibr5-1753466619898598]--[@bibr6-1753466619898598]^

Airflow limitations {#section6-1753466619898598}
-------------------

Airflow limitation is a defining feature of asthma. It is suggested that in a mild and moderate disease, airway narrowing is tidal and fully reversible. In severe asthma, however, airway obstruction may become permanent and less responsive to treatment.^[@bibr7-1753466619898598],[@bibr8-1753466619898598]^ Bronchial remodelling is defined as a thickening of the bronchial wall due to the increase of smooth muscle mass, mucous gland hypertrophy, neoangiogenesis and sub-epithelial membrane thickening. Fixed obstruction in severe asthma tends to mimic clinically chronic obstructive pulmonary disease (COPD). The overlap of clinical presentation of asthma and COPD brings difficulties in clinical practice and remains a significant concern. Modern imaging techniques may provide an insight into the complexity of the airway structure and the physiopathology of obstructive diseases. qCT is used in studying bronchial wall remodelling, its relationship with airflow limitation and other clinical outcomes.^[@bibr9-1753466619898598][@bibr10-1753466619898598]--[@bibr11-1753466619898598]^

Tsurikisawa and colleagues demonstrated a significant correlation between the duration of asthma and airway structural changes.^[@bibr12-1753466619898598]^ Berair and colleagues described the associations between qCT and endobronchial biopsy specimens. The authors showed a significant correlation between bronchial cross-sectional lumen area and the epithelial thickness, especially in proximal airways.^[@bibr9-1753466619898598]^ A clear relationship was found between the airway dimension decrease, observed in computed tomography, and the airflow limitation in lung function tests.^[@bibr10-1753466619898598]^ Previous studies demonstrated this relationship in proximal airways.^[@bibr9-1753466619898598],[@bibr10-1753466619898598]^

This prospective study aimed to evaluate the usefulness of quantitative multi-slice computed tomography in the assessment of airway wall thickness and for verification of the relationship between the structural change of the bronchial tree and the airflow limitation in patients with asthma.

Materials and methods {#section7-1753466619898598}
=====================

The study was approved by The Bioethics Committee of the Wroclaw Medical University (No. KB -- 280/2014). Informed consent for the study was obtained from all the subjects before conducting any study procedures. The study was conducted according to the World Medical Association Declaration of Helsinki.

Patient population {#section8-1753466619898598}
------------------

In this single academic centre study, we studied prospectively 83 patients (49 female and 34 male) with chronic asthma and 30 healthy volunteers (12 female and 18 male). ([Table 1](#table1-1753466619898598){ref-type="table"}) The average age of participants was 46.76 (SD = 13.38) years. All subjects, in both groups, were non-smokers. Asthma was diagnosed according to the Global Initiative for Asthma (GINA) 2015 recommendations regarding definition, diagnosis and assessment of asthma severity. The diagnosis was made by experienced allergists and pulmonologists and was based on the history of asthma symptoms, variable over time airflow limitation, bronchodilator testing and in some cases provocation testing.^[@bibr13-1753466619898598]^ All patients were recruited from the allergological outpatient clinic of our university. In 10 cases (9 asthma and 1 healthy volunteer) quantitative image reconstructions were not possible because of motion artefacts (*n* = 3) and system errors (*n* = 7), which prevent image reconstructions. In total, four patients were excluded from the final analysis due to the diagnosis of another disease. [Figure 1](#fig1-1753466619898598){ref-type="fig"} presents the flowchart of examined participants.

###### 

Patients characteristics -- mean values (SD) in patients with asthma and healthy controls.

![](10.1177_1753466619898598-table1)

  Parameters           Asthma          Control group    *p* value
  -------------------- --------------- ---------------- -----------
  Age (years)          45.40 (12.73)   47.07 (13.01)    ns
  Height (cm)          169.1 (8.98)    172.67 (9.21)    ns
  Weight (kg)          77.52 (17.97)   81.63 (16.27)    ns
  Sex (F/M)            49/34           12/18            ns
  BMI                  27.01 (5.52)    27.31 (5.06)     ns
  BSA (m^2^)           1.88 (0.32)     1.97 (0.25)      ns
  FEV~1~ (Litres)      2.53 (1.02)     3.68 (1.06)      \<0.0001
  FEV1 (% predicted)   81.31 (23.64)   108.35 (12.64)   \<0.0001
  FEV1/FVC%            64.94 (12.00)   77.57 (5.80)     \<0.0001
  FVC (Litres)         3.91 (1.25)     4.74 (1.31)      0.0027
  FVC (% predicted)    107.2 (24.68)   115.9 (12.48)    ns
  FEF~75~              3.97 (2.06)     6.70 (2.14)      \<0.0001
  FEF~50~              2.08 (1.51)     4.02 (1.66)      \<0.0001
  R~OCC~               0.66 (0.32)     0.48 (0.18)      0.0038

BMI, body mass index; BSA, body surface area; FEF~25--75~, mid forced expiratory flow at 50--75% of the forced vital capacity; FEV~1~, forced expiratory volume in 1 s; FVC, forced vital capacity; ns, not significant; R~occ~, respiratory resistance; SD, standard deviation.

![Patients flowchart.](10.1177_1753466619898598-fig1){#fig1-1753466619898598}

The study group was composed of 25 subjects with severe refractory asthma, 28 with moderate asthma and 30 patients with mild asthma. The refractory asthma referred to patients with irreversible airflow limitation despite step 5 treatment. All patients were examined in a stable, well-controlled condition according to the Asthma Control Test™ (score of 20--25) and at least 4 weeks after their last exacerbation. Patients were asked to refrain from taking inhaled bronchodilators before the examination, according to the summary of product characteristics (at least 8 h in the case of short-term and 24 h in the case of long-term bronchodilators, respectively).

Computed tomography scanning {#section9-1753466619898598}
----------------------------

All the CT studies were performed using a 128 multi-slice CT scanner (SOMATOM Definition AS+, Siemens Healthcare, Erlangen, Germany) with a non-contrast chest scanning protocol.

Automatic exposure control with reference values of 120 kV and 100 mA, or 100 kV, 110 mA (Care4Dose, Siemens Healthcare, Erlangen, Germany) and iterative reconstruction algorithm (SAFIRE, Siemens Healthcare, Erlangen, Germany) were used to reduce and optimise the radiation dose. Other scanning parameters were as follows: 128 × 0.6 mm collimation, pitch 1.2 mm, rotation time 0.5 s, high-resolution matrix 512 × 512 px.

All patients were examined in the supine position, craniocaudal direction at full inspiration and breath-holds. Before scanning, all patients were carefully instructed in detail how to perform the manoeuvre correctly.

The images were viewed and analysed on a dedicated workstation with *Syngo.*via and *Syngo.*Pulmo3D (Siemens Healthcare, Erlangen, Germany) on a lung and mediastinal window settings (lung: WW 1500 HU, WL --600 HU, mediastinal WW 400 HU, WL 40 HU). The 3D model of the bronchial tree was extracted with the volume rendering technique presented in [Figure 2](#fig2-1753466619898598){ref-type="fig"}. Further, the appropriate bronchus was selected and displayed in the enlarged, axial window ([Figure 3](#fig3-1753466619898598){ref-type="fig"}). Virtual bronchoscopy of the CT was used to navigate and show the position of the measurement.

![The bronchial tree segmentation. *Syngo*.via. Pulmo3D (a) AP projection and (b) lateral projection.](10.1177_1753466619898598-fig2){#fig2-1753466619898598}

![The measurements of the airway from 3rd to 10th generations of the bronchi. *Syngo*.via. Pulmo3D (D1 value is described in the text as OD, D2 value is described in the text as ID)](10.1177_1753466619898598-fig3){#fig3-1753466619898598}

We obtained quantitative parameters of the bronchial tree from the 3rd up to the 9th generations of the right lung. The segmental bronchus was considered the third generation of the bronchial tree. The respiratory tracts were measured in cross-sectional scans, perpendicular to the long axis. The outer diameter (OD) was expressed as the total diameter of the bronchi, the inner diameter (ID) was measured as the luminal diameter. The mean wall thickness (WT) was calculated according to the equation

$$WT = \frac{\begin{array}{l}
{\left( {\left( {shortest\ \ OD\ \  + \ \ longest\ \ OD} \right)/2} \right) -} \\
\left( {\left( {shortest\ \ ID\ \  + \ \ longest\ \ ID} \right)/2} \right) \\
\end{array}}{2}$$

The wall area (WA), the lumen area (LA) and the percentage of the WA (WA%) were automatically calculated as the proper parts of the cross-sectional total airway area. A graphical presentation of the measurements is shown in [Figure 4](#fig4-1753466619898598){ref-type="fig"}.

![Bronchial tree main parameters: OD, ID, WT, WA, LA.](10.1177_1753466619898598-fig4){#fig4-1753466619898598}

All measurements were performed by one experienced observer with no knowledge of the past medical history of the patients. The intraobserver agreement of measurements of the WT3-WT5 was completed in a group of 30 randomly chosen subjects. There was a 4-month interval between consecutive measurements.

Lung function tests {#section10-1753466619898598}
-------------------

Spirometry and airway resistance measurements were performed using the Jaeger MasterScope spirometer on the same day as the CT scans. We measured forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF) and respiratory resistance (R~occ~). FEV1/FVC %, FEV1/VC max% were computed according to GINA guidelines.

Statistical analysis {#section11-1753466619898598}
--------------------

The statistical analysis was performed using the GraphPad Prism v.6.0 (GraphPad Software, California, USA) and the MS Office Excel 2016 (Microsoft, Redmond, USA). The Shapiro--Wilk test and the D'Agostino--Pearson omnibus normality test were used to verify the normal distribution. The chi-square test was used to assess the frequency distribution in the examined groups. The comparison of the two groups was performed using the Mann--Whitney *U* test and presented as a median value and an interquartile range. Correlation coefficients between the factors were assessed with Spearman's rank correlation coefficient. The reproducibility of the measurements was assessed with the Bland--Altman test.

Results {#section12-1753466619898598}
=======

Image reconstructions and the airway segmentation from the third to the seventh generations of the bronchi were possible in nearly all examined subjects (*n* = 99). The eighth bronchial generation was attainable in 82% (*n* = 82), whereas the ninth in 62% (*n* = 62) of the subjects. The chi-square test revealed no statistical difference in the frequency of the obtained bronchial divisions between the study and the control groups.

The WT in patients with asthma was significantly larger in all measured generations of the bronchial tree (third to ninth generation) ([Table 2](#table2-1753466619898598){ref-type="table"}). The OD and the total cross-sectional WA of all bronchial generations were similar in both groups. The cross-sectional WA% from WA4% to WA9% was significantly bigger in asthmatic patients (*p* \< 0.05). The LA and the ID from the seventh to the ninth generations were significantly smaller in the asthmatic group (*p* \< 0.05). More detailed parameters are presented in [Tables 3](#table3-1753466619898598){ref-type="table"} and [4](#table4-1753466619898598){ref-type="table"}.

###### 

Wall thickness median values (SD) in patients with asthma and healthy controls (Mann--Whitney *U* test).

![](10.1177_1753466619898598-table2)

        Asthma   Control group   *p* value                             
  ----- -------- --------------- ------------ ---- ------ ------------ ----------
  WT3   70       2.34            2.07--2.58   29   2.1    1.74--2.43   0.0224
  WT4   70       2.24            1.97--2.42   29   1.75   1.60--2.14   \<0.0001
  WT5   70       1.84            1.66--2.05   29   1.63   1.43--1.87   0.0011
  WT6   70       1.64            1.52--1.80   29   1.49   1.37--1.57   \<0.0001
  WT7   67       1.53            1.44--1.66   27   1.46   1.32--1.56   0.0433
  WT8   57       1.50            1.36--1.59   25   1.35   1.27--1.49   0.0015
  WT9   41       1.38            1.30--1.50   21   1.34   1.21--1.41   0.0444

3--9, following generations of the bronchial tree; IQR, interquartile range; WT, wall thickness.

###### 

Lumen area the median values and interquartile range (Mann--Whitney *U* test).

![](10.1177_1753466619898598-table3)

        Asthma   Control group   *p* value                                  
  ----- -------- --------------- -------------- ---- ------- -------------- --------
  LA3   70       48.94           40.55--67.13   28   51.70   45.97--58.51   ns
  LA4   70       35.47           29.33--42.80   28   33.36   27.39--39.46   ns
  LA5   70       24.07           19.59--29.79   28   25.64   17.80--31.49   ns
  LA6   70       15.50           11.63--21.06   28   16.79   13.48--20.11   ns
  LA7   64       9.20            6.89--13.08    24   11.58   9.95--16.09    0.0031
  LA8   54       6.49            4.50--8.70     21   7.91    5.97--12.04    0.0141
  LA9   38       3.45            2.86--5.61     18   5.18    4.19--6.32     0.0078

3--9, following generations of the bronchial tree; IQR, interquartile range; LA, lumen area; ns, not significant.

###### 

The measurements of the inner diameter the median values and SD. (Mann--Whitney *U* test).

![](10.1177_1753466619898598-table4)

        Asthma   Control group   *p* value                             
  ----- -------- --------------- ------------ ---- ------ ------------ --------
  ID3   70       7.73            7.14--9.37   29   8.39   7.53--8.80   ns
  ID4   70       6.71            6.08--7.41   29   6.47   5.98--7.36   ns
  ID5   70       5.51            4.95--6.07   29   5.83   4.79--6.67   ns
  ID6   70       4.42            3.83--5.18   29   4.94   4.31--5.23   ns
  ID7   67       3.43            2.96--4.14   27   3.83   3.48--4.24   0.0403
  ID8   57       2.84            2.39--3.35   25   3.12   2.67--3.70   0.0437
  ID9   40       2.10            1.84--2.50   20   2.53   2.39--2.96   0.0005

3--9, following generations of the bronchial tree; ID, inner diameter; IQR, interquartile range; ns, not significant.

Statistically significant differences between the examined and the control groups (*p* \< 0.05) were found in most lung function tests parameters. The most important are listed in [Table 1](#table1-1753466619898598){ref-type="table"} -- patients characteristics. The analysis of the airway resistance values (R~occ~) showed a significantly higher resistance in the airways in the study group (*p* = 0.0038) in relation to the control group.

Our study presents a significant relationship between the qCT parameters and the Lung Function Test in the group of patients with asthma. LA and ID positively correlate with FEV~1~ and FVC (*p* \< 0.05). A negative, weak correlation of the LA and ID with the airway's resistance was observed except the fifth and eighth generations (*p* = 0.003). Values of the correlation coefficients are listed in [Table 5](#table5-1753466619898598){ref-type="table"}. There was no statistically significant correlation between PEF and qCT parameters.

###### 

Correlation between LA and ID and selected lung function tests in the group of patients with asthma.

![](10.1177_1753466619898598-table5)

  Parameter   *n*   FEV1 (Litre)   R~OCC~ (kPa × s/Litre)             
  ----------- ----- -------------- ------------------------ --------- --------
  LA3         70    0.2972         0.0078                   −0.2312   0.0474
  LA4         70    0.3601         0.001                    −0.2925   0.0109
  LA5         70    0.3122         0.0048                   ns        ns
  LA6         70    0.2765         0.013                    −0.3359   0.0032
  LA7         64    0.2345         0.0388                   −0.2959   0.0105
  LA8         54    0.2931         0.0161                   ns        ns
  LA9         38    0.4018         0.0032                   −0.3843   0.0064
  ID3         70    0.2937         0.0082                   −0.2489   0.0313
  ID4         70    0.3982         0.0003                   −0.2972   0.0096
  ID5         70    0.3364         0.0023                   −0.1033   0.3779
  ID6         70    0.3248         0.0033                   −0.3163   0.0057
  ID7         67    0.2613         0.0209                   −0.2791   0.0161
  ID8         57    0.2975         0.0145                   ns        ns
  ID9         40    0.3461         0.012                    −0.3731   0.0083

3--9, following generations of the bronchial tree; ID, inner diameter; LA, lumen area; ns, not significant; *r*-value, Spearman's rank correlation coefficient; R~occ~, respiratory resistance.

Correlation coefficients were calculated with Spearman's rank correlation coefficient, *p* values of \< 0.05 were considered significant.

The Bland--Altman test revealed small intraobserver bias between measurements of the WT3-WT5. The reproducibility graphs are presented in [Figure 5](#fig5-1753466619898598){ref-type="fig"}.

![Bland--Altman plots of wall thickness measurements agreement (a) WT 3; (b) WT 4; and (c) WT 5.](10.1177_1753466619898598-fig5){#fig5-1753466619898598}

Discussion {#section13-1753466619898598}
==========

The use of 128-slice computed tomography scanners and advanced post-processing software enables us to obtain quantitative data of the airway up to the ninth generation of the bronchial tract, which is a considerable improvement.^[@bibr9-1753466619898598],[@bibr11-1753466619898598]^ Most of the previous studies focusing on the parameters in obstructive airway diseases involved measurements of proximal airways -- up to the sixth generation.^[@bibr4-1753466619898598],[@bibr6-1753466619898598],[@bibr10-1753466619898598],[@bibr14-1753466619898598]^ Li and colleagues in the study investigating sex-related differences in COPD, using CT with automatic measurements, extracted bronchi up to the seventh generation.^[@bibr15-1753466619898598]^ The median values of WT from the fifth to the seventh generations observed in our study were slightly higher than those reported in the study by Li and colleagues. This result could be associated, first, with the ethnic differences, second, with the different post-processing software used, and third, with the different patient characteristics.

Our study presents a significantly higher value of WT in all assessed bronchial generations and a larger WA4%--WA9% in patients with asthma than in the control group. Similar results were reported in other studies, but mainly within the proximal airways.^[@bibr16-1753466619898598][@bibr17-1753466619898598]--[@bibr18-1753466619898598]^ Gono and colleagues compared normal, healthy subjects with two groups of asthmatic patients -- symptomatic and asymptomatic -- using high-resolution CT. They showed significant differences in WT, WA%, and WA of the right B1 segmental bronchus in the symptomatic group.^[@bibr19-1753466619898598]^ The analysis of the airway dimensions in the chest using multidetector CT scans was performed in 2009 by Hoshino and colleagues. They reported differences in patients with asthma of different degrees of severity. A significant correlation between CT airway parameters and lung function tests was stated. The authors suggested that the airflow limitations could be associated mostly with the distal bronchi.^[@bibr10-1753466619898598]^ We found that the LA and ID from the seventh to the ninth generations were significantly smaller in the examined group than in the control group, whereas there were no significant differences in proximal airways. Moreover, we described the relationship between LA, ID and LFTs -- mainly FEV1 -- and we noticed that the correlation coefficients tend to increase with more distal bronchi. We also found a negative, weak correlation of the LA and the ID with the airway's resistance value, except for the fifth and eighth generations.

We hypothesise that a combination of airway thickness assessment and adequately adjusted treatment can result in the optimisation of asthma management, the formulation of the most efficient treatment algorithms and minimize the side effects of therapy in future.

There were several potential limitations of our study. First, we did not discriminate patients according to asthma severity. Some essential differences might potentially be noticed.^[@bibr10-1753466619898598]^ Second, we performed measurements only in the posterior basal bronchus of the right lung (B10), assuming that the distribution of changes in the airways should be regular in both lungs. Third, the image analysis was performed by only one observer. The inter observer evaluations for the further studies may be more objective. Owing to the scanning protocol (only full-inspire CT scans), we did not perform the assessment of lung densitometry. Dose reduction protocols were enabled in this study, which resulted in different radiation parameters for each patient.

Conclusion {#section14-1753466619898598}
==========

The study showed increased airway thickness in patients with asthma compared with healthy volunteers. More changes were noticed in the medium, and small airways (fifth to the ninth generation of the bronchi). The correlations revealed between qCT and LFT indicate the usefulness of the imaging techniques and their post-processing methods in the diagnosis and management of asthma. Further studies on the relationship between airway thickness, airflow limitation, severity of asthma and different treatment algorithms will possibly bring further improvement in asthma management and prognosis.
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